Man Group’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,001
Closed -$894K 2123
2025
Q1
$894K Buy
+14,001
New +$894K ﹤0.01% 1403
2024
Q4
Sell
-311,338
Closed -$38.9M 2021
2024
Q3
$38.9M Sell
311,338
-75,086
-19% -$9.38M 0.1% 237
2024
Q2
$61.1M Buy
386,424
+266,419
+222% +$42.1M 0.15% 147
2024
Q1
$15.5M Buy
+120,005
New +$15.5M 0.04% 501
2023
Q2
Hold
0
-$216K 2156
2023
Q1
Sell
-81,744
Closed -$10.6M 1759
2022
Q4
$10.6M Buy
81,744
+10,344
+14% +$1.34M 0.04% 540
2022
Q3
$7.89M Buy
+71,400
New +$7.89M 0.04% 560
2022
Q2
Sell
-16,519
Closed -$1.29M 1644
2022
Q1
$1.29M Buy
+16,519
New +$1.29M ﹤0.01% 1302
2021
Q4
Sell
-31,819
Closed -$2.94M 1988
2021
Q3
$2.94M Buy
31,819
+14,063
+79% +$1.3M 0.01% 1041
2021
Q2
$1.38M Buy
17,756
+7,498
+73% +$583K ﹤0.01% 1313
2021
Q1
$765K Buy
10,258
+22
+0.2% +$1.64K ﹤0.01% 1361
2020
Q4
$1.75M Sell
10,236
-30,177
-75% -$5.14M 0.01% 1248
2020
Q3
$5.68M Sell
40,413
-2,038
-5% -$286K 0.02% 744
2020
Q2
$6.81M Buy
+42,451
New +$6.81M 0.03% 523
2019
Q4
Sell
-17,254
Closed -$1.3M 1900
2019
Q3
$1.3M Sell
17,254
-14,446
-46% -$1.09M ﹤0.01% 1363
2019
Q2
$4.82M Sell
31,700
-8,082
-20% -$1.23M 0.02% 960
2019
Q1
$4.74M Buy
39,782
+37,282
+1,491% +$4.44M 0.02% 946
2018
Q4
$273K Sell
2,500
-6,435
-72% -$703K ﹤0.01% 1746
2018
Q3
$1.44M Buy
8,935
+6,435
+257% +$1.04M 0.01% 1516
2018
Q2
$330K Buy
+2,500
New +$330K ﹤0.01% 1886